Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China

World Journal of Gastroenterology

Volumn 9, Issue 1, 2003, Pages 16-21

  Chen, Hong ^a   Wang, Li Dong ^a   Guo, Mei ^b   Gao, She Gan ^a   Guo, Hua Qin ^a   Fan, Zong Min ^a   Li, Ji Lin ^c  

^a ZHENGZHOU UNIVERSITY   (China)

^b Anyang City Tumor Hospital   (China)

^c Yaocun Esophageal Hospital of Anyang   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; PROTEIN P53;

ADULT; AGED; ARTICLE; BASAL CELL; CANCER GROWTH; CANCER INCIDENCE; CARCINOMA IN SITU; CARDIA; CARDIA CARCINOMA; CELL HYPERPLASIA; CHI SQUARE TEST; CHINA; CLINICAL ARTICLE; CLINICAL OBSERVATION; DYSPLASIA; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS INJURY; ESOPHAGUS MUCOSA; FEMALE; FISHER EXACT TEST; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MANTEL HAENSZEL TEST; MOLECULAR BIOLOGY; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; RISK FACTOR; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; STATISTICS; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH EPITHELIUM;

EID: 0037439219     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i1.16     Document Type: Article

References (44)

1. Wang LD, Zhou Q, Yang CS. Esophageal and gastric cardia epithelial cell proliferation in northern Chinese subjects living in a high-incidence area. J Cell Biochem Suppls 1997; 28/29: 159-165
2. Correa P. Precursors of gastric and esophageal cancer. Cancer 1982; 50: 2554-2565
3. Lu JB, Yang WX, Zu SK, Chang QL, Sun XB, Lu WQ, Quan PL, Qin YM. Cancer mortality and mortality trends in Henan, China, 1974-1985. Cancer Detect Prev 1988; 13: 167-173
4. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 2960
5. Blot WJ, Devesa SS, Fraumeni JF. Continuing climb in rates of esophageal adenocarcinoma: An update. JAMA 1993; 270: 1320
6. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagastric junction. Gastroenterology 1993; 104: 510-513
7. Botterweck AA, Schouten LJ, Volovics A, Dorant E, Van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 645-654
8. Hainaut P, Soussi T, Shomer B, Hollstein M, Greenblatt M, Hovig E, Harris CC, Montesano R. Database of p53 gene somatic mutation in human tumors and cell lines: Updated compilation and future prospects. Nucleic Acid Res 1997; 25: 151-157
9. Gao SS, Zhou Q, Li YX, Bai YM, Zheng ZY, Zou JX, Liu G, Fan ZM, Qi YJ, Zhao X, Wang LD. Comparative studies on epithelial lesions at gastric cardia and pyloric antrum in subjects from a high incidence area for esophageal cancer in Henan, China. World J Gastroenterol 1998; 4: 332-333
10. Zhou HP, Cao XF. Six cases of esophageal carcinoma with concomitant tumors of the gastric cardia. Zhonghua Waike Zazhi 1987; 25: 700
11. Yao SC. Nine cases report of primary esophageal and gastric cardia cancers. Zhongliu 1987; 7: 121
12. Zhou FY, Ma JS, Han XC. Repetitive primary carcinomas concurrently occurring in the esophagus and gastric cardia. Henan Zhongliuxue Zazhi 1996; 9: 357-358
13. Wang L, Zhang S. Twenty-eight cases report of the concurrent cancers of esophagus and gastric cardia. Jining Yixueyuan Xuebao 1996; 19: 43-44
14. Wang LD, Chen H. Alterations of tumor suppressor gene p53-Rb system and human esophageal carcinogenesis. Shijie Huaren Xiaohua Zazhi 2002; 9: 367-371
15. Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 1994; 54: 4342-4346
16. Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, Harris CC, Montesano R. IARC database of p53 gene mutation in human tumors and cell lines: Updated compilation, revised formats and new visualization tools. Nucleic Acids Res 1998; 26: 205-213
17. Bennett WP, Hollstein MC, He A, Zhu SM, Resau JH, Trump BF, Metcalf RA, Welsh JA, Midgley C, Lane DP. Archival analysis of p53 genetic and protein alterations in Chinese esophageal Cancer. Oncogene 1991; 6: 1779-1784
18. Shi ST, Yang GY, Wang LD, Xue Z, Feng B, Ding W, Xing EP, Yang CS. Role of P53 gene mutations in human esophageal carcinogenesis: Results from immunohistochemical and mutation analysis of carcinomas and nearby non-cancerous lesions. Carcinogenesis 1999; 20: 591-597
19. Harris CC. Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies. J Natl Cancer Inst 1996; 88: 1442-1455
20. Sidransky D, Hollstein M. Clinical implications of the p53 gene. Annu Rev Med 1996; 47: 285-301
21. Li HC, Lu SX. Mutation of p53 gene in human cancers of the esophagus and gastric cardia. Zhonghua Zhongliu Zazhi 1994; 16: 172-176
22. Yue WB, Wang LD, Ding I. Detection of angiogenic growth factors in patients with precancerous and cancerous lesions of esophagus from high-risk area in Henan, China. World J Gastroenterol 1998; 4(Suppl 2): 109
23. He LJ, Wu M. The distribution of esophageal and cardiac carcinoma and precanceous of 2238. World J Gastroenterol 1998; 4(Suppl 2): 100
24. Xu T, Fang LP, Li J, Liu WQ, Zhou ZY, Qiu CP, Yu XH, Si TP, He LJ, Fang XL, Meng ZH, Li YH, Jiang LH, Luo DY. A pathologic analysis of 4451 cases with digestive tract cancer. World J Gastroenterol 1998; 4 (Suppl 2): 65-66
25. Gerdes J, Schwab U, Seeub H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20
26. Wang LD, Hong JY, Qiu SL, Gao HG, Yang CS. Accumulation of p53 protein in human esophageal precancerous lesions: A possible early biomarker for carcinogenesis. Cancer Res 1993; 53: 1783-1787
27. Hermanek P, Hutter RVP, Sobin LH. International Union Against Cancer (UICC). TNM atlas, 4th edition. Berlin: Springer 1997
28. Warren S, Gates P. Multiple primary malignant tumors. A survey of literature and a statistical study. Am J Cancer 1932; 16: 1358-1414
29. Moertel CG. Multiple primary malignant neoplasms. Cancer 1977; 40: 1786
30. Esophageal Cancer. Du BL (editor). Beijing: Chinese Science and Technology Publishing Company 1994
31. Wang LD, Shi ST, Zhou Q, Goldstein S, Hong JY, Shao P, Qiu SL, Yang CS. Changes in P53 and cyclin D1 protein level and cell proliferation in different stages of Henan esophageal and gastric-cardia carcinogenesis. Int J Cancer 1994; 59: 514-519
32. Shen MZ, Wang G, Qiu SL. Stomach cancer, Chinese stomach tumor collaborative research group editor. Shenyang: Liaoning People Publishing Company 1981
33. Biemer-Huttmann AE, Walsh MD, McGuckin MA, Ajioka Y, Watanabe H, Leggett BA, Jass JR. Immunohistochemical staining patterns of Mucin1, Mucin2, Mucin4 and Mucin5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum. J Histochem Cytochem 1999; 47: 1039-1048
34. Reis CA, David L, Correa P, Carneiro F, De Bolos C, Garcia E, Mandel U, Clausen H, Sobrinho-Simoes M. Intestinal metaplasia of human stomach displays distinct patterns of mucin expression. Cancer Res 1999; 59: 1003-1007
35. Moertel CG, Dockerty MB. Multiple primary malignant neoplasms: Tumors of different tissues or organs. Cancer 1961; 14: 231-237
36. Slauhgter TP, Soutwick HW, Smejkel W. Field cancerization in oral stratified epithelium. Cancer 1953; 6: 963-968
37. Lu SX. Alterations of oncogenes and tumor suppressor genes in esophageal cancer in China. Mutation Res 2000; 462: 343-353
38. Liu B, Wang LD. Barrett's esophagus. Huaren Xiaohua Zazhi 1999; 3: 3-7
39. Mandard AM, Hainaut P, Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutation Res 2000; 462: 335-342
40. Zou JX, Wang LD, Shi Stephanie T, Yang GY, Xue ZH, Gao SS, Li YX, Yang Chung S. p53 gene mutations in multifocal esophageal precancerous and cancerous lesions in patients with esophageal cancer in high-risk northern China. Shijie Huaren Xiaohua Zazhi 1999; 7: 280-284
41. Wang YK, Ji XL, Gu YG, Zhang SC, Xiao JH. P53 and PCNA expression in glandular dilatation of gastric mucosa. China Natl J New Gastroenterol 1996; 2: 106-108
42. Wang LD, Zhou Q, Gao SS, Li YX, Yang WC. Measurements of cell proliferation in esophageal and gastric cardia epithelia of subjects in a high incidence area for esophageal cancer. China Natl J New Gastroenterol 1996; 2: 82-85
43. Wang LD, Yang WC, Zhou Q, Xing Y, Jia YY, Zhao X. Changes of p53 and Waf1p21 and cell proliferation in esophageal carcinogenesis. China Natl J New Gastroenterol 1997; 3: 87-89
44. Wang LD, Zhou Q, Wei JP. Yang WC, Zhao X, Wang LX, Zou JX, Gao SS, Li YX, Yang CS. Apoptosis and its relationship with cell proliferation, p53, Waf1p21, bcl-2 and c-myc in esophageal carcinogenesis studied with a high-risk population in northern China. World J Gastroenterol 1998; 4: 287-293